News Briefs
✦ Bristol Myers Squibb will voluntarily withdraw the U.S. indication for Opdivo (nivolumab) as a monotherapy for people with hepatocellular carcinoma who previously were treated with sorafenib. The move follows an...
News Briefs
✦ The bipartisan infrastructure package that U.S. senators are currently negotiating will further delay a never-implemented regulation that would restructure the Medicare Part D drug rebate system, various news ou...
News Briefs
✦ HHS Secretary Xavier Becerra renewed the COVID-19 public health emergency (PHE) for an additional 90 days on July 19. The decision was something of a formality, as statements by Biden administration officials ha...
News Briefs
✦ AARP launched a seven-figure, digital ad campaign on July 19 aimed at pressing Congress to support actions to lower drug prices, The Hill reported. The campaign will appear in The New York Times, The Washington ...
News Briefs
✦ More than two million people have signed up for health care coverage during the pandemic special enrollment period on HealthCare.gov, according to CMS. Signups have undoubtedly been boosted by the expanded premi...
News Briefs
✦ Sens. Bill Cassidy, M.D. (R-La.) and Bob Menendez (D-N.J.) on July 14 introduced legislation seeking to redesign the Medicare Part D benefit structure and limit seniors’ out-of-pocket (OOP) drug costs. The bip...
News Briefs
✦ President Joe Biden was slated to issue an executive order on July 9 aimed at “promoting competition in the American economy,” which notably includes the health care sector. It calls on federal agencies to ...
News Briefs
✦ Eli Lilly & Co. is making a direct equity investment in MiNA Therapeutics Limited, a company that describes itself as “the pioneer in small activating RNA therapeutics.” Lilly’s investment of $15 milli...
News Briefs
✦ Merck & Co., Inc. will voluntarily withdraw the accelerated approval indication for Keytruda (pembrolizumab) for the treatment of people with recurrent locally advanced or metastatic gastric or gastroesophag...
News Briefs
✦ The Biden administration on July 1 released a regulation that takes the first step toward implementing the No Surprises Act, which bans surprise medical billing. The rule, which was the subject of fierce lobbyin...